Banner Top
Wednesday, May 18, 2022

With the coronavirus pandemic stressing the need for innovation more than ever before, there is renewed hope within the pharma sector of a R&D policy being finally announced in the budget this year. Over the last few months, there have been discussions between the department of pharma and industry bodies over R&D incentives, with the government readying a draft on the issue.

Banner Content


Leave a Comment